Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levulan PDT for Actinic Keratoses on Upper Extremities
NCT01458587Phase 2Completed
- Sponsor
- DUSA Pharmaceuticals
- Start
- Nov 2011
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 5-aminolevulinic acid in actinic keratosis (AK), sponsored by DUSA Pharmaceuticals. Started Nov 2011; status: completed.
02
Drugs
5-aminolevulinic acid
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT01458587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01458587.